002349 Jinghua Pharmaceutical Group
- 6.68
- +0.06+0.91%
Jinghua Pharmaceutical Group News
Jinghua Pharmaceutical: Announcement on Sale of Shares in Holding Subsidiaries
Jinghua Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Jinghua Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Jinghua Pharmaceutical: Announcement on the company's holding of US KADMON shares to complete the tender offer
Jinghua Pharmaceutical: Announcement on the completion of the sale of shares in participating subsidiaries
Jinghua Pharmaceutical: Announcement on the progress of the sale of shares in participating subsidiaries
Jinghua Pharmaceutical: Announcement on sale of shares in participating subsidiaries
Jinghua Pharmaceutical: Announcement on sale of shares in participating subsidiaries
Jinghua Pharmaceutical: Notice on the termination of the company's public issuance of convertible corporate bonds and the withdrawal of application documents
Jinghua Pharmaceutical: Notice on Supplemental Response to Feedback on Application Documents for the Public Issuance of Convertible Corporate Bonds
Jinghua Pharmaceutical: Notice on Risk Alerts and Remediation Measures for the Company's Public Issuance of Convertible Corporate Bonds to Dilute Immediate Returns (Revised Draft) and Related Entities' Commitments
Jinghua Pharmaceutical: Notice on Adjusting the Company's Plan for Publicly Issuing Convertible Corporate Bonds
Jinghua Pharmaceutical: Notice on Adjusting the Company's Plan for Publicly Issuing Convertible Corporate Bonds
Jinghua Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds (Revised Draft)
Jinghua Pharmaceutical: Announcement on sale of shares in participating subsidiaries
Jinghua Pharmaceutical: Announcement on the acceptance of the application for the public issuance of convertible corporate bonds by the China Securities Regulatory Commission
Jinghua Pharmaceutical: Announcement on the company's public offering of convertible bonds approved by the Jiangsu Provincial State-owned Assets Administration Commission
Jinghua Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds
Jinghua Pharmaceutical: Announcement on Risk Alerts and Remediation Measures and Related Entities' Commitments for the Company's Public Issuance of Convertible Corporate Bonds to Dilute Immediate Returns
Jinghua Pharmaceutical: Announcement on the Company's Obtaining a Real Estate Title Certificate
Analysis
Price Target
No Data
